Follicular lymphoma grade III, unspecified, intrathoracic lymph nodes
ICD-10 C82.22 is a billable code used to indicate a diagnosis of follicular lymphoma grade iii, unspecified, intrathoracic lymph nodes.
Follicular lymphoma is a type of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. Grade III follicular lymphoma indicates a more aggressive form of the disease, with a higher proliferation index and a greater likelihood of transformation to a more aggressive lymphoma. The designation 'unspecified' indicates that the specific characteristics of the lymphoma have not been detailed. When this lymphoma affects intrathoracic lymph nodes, it may present with symptoms such as cough, chest pain, or respiratory distress due to lymphadenopathy. Staging of follicular lymphoma is crucial for determining prognosis and treatment options, typically using the Ann Arbor staging system. B-symptoms, which include fever, night sweats, and weight loss, may also be present and are significant in assessing the disease's severity. Treatment protocols often involve a combination of chemotherapy, immunotherapy, and sometimes radiation therapy, depending on the stage and symptoms. Regular follow-up and monitoring are essential due to the potential for relapse.
Comprehensive documentation of diagnosis, staging, treatment plans, and follow-up care.
Diagnosis of follicular lymphoma, treatment planning, and management of complications.
Ensure accurate grading and staging are documented to support coding.
Detailed imaging reports indicating lymph node involvement and any changes over time.
Imaging studies to assess lymphadenopathy and response to treatment.
Radiology reports should clearly indicate the location and size of lymph nodes.
Used for patients receiving chemotherapy for follicular lymphoma.
Document the specific chemotherapy regimen and patient response.
Oncology specialists should ensure accurate coding of chemotherapy administration.
Common symptoms include painless swelling of lymph nodes, fever, night sweats, weight loss, and fatigue. Some patients may also experience B-symptoms, which are significant in assessing the disease's severity.
